Interleukin-6 level in male COVID-19 patients in Iraq

Abstract

Background: Since the exacerbation of the Coronal Virus 2019, caused by the SARS-COV-2 Virus in December 2019, affected more than 200 countries, region or region on 6 continents. Currently, the rates of infection for the male sex were higher than the female. The aim of this study was to assess the levels of Interleukin-6, the male-infected Iraqi patients with Covid-19. Methods: Clinical features, laboratory results and PCR actual time have been reviewed by 60 patients with a certain laboratory COVID-19 virus. They entered Al -Amal Hospital. Iraq between September and December 2021. Healthy participants who underwent routine physical examinations and non-patients with COVID-19 was the study as a control group. Homocysteine and IL6 levels have been identified and compared between the obese COVID-19 group and the control group. Results: The results showed that the levels of interleukin-6 were higher than the normal range for patients with COVID-19 compared to the control group, while the levels of interleukin-6 for the obese recorded the highest reading among the three groups. The lipid profile levels were high in the obese group of patients with COVID-19, while the non-obese patients with COVID-19 had a lower lipid profile compared to the healthy control group.